Vir Biotechnology, Inc.
VIR· Nasdaq
Released Aug 11, 2020, after the close
10-Q filed Aug 11, 2020, 42 days after period end · 0001564590-20-039295
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $66.99M | $2.05M | $2.22M |
| Net Income | -$31.17M | -$33.93M | -$24.45M |
| EPS Diluted | -$0.27 | -$3.64 | -$3.35 |
Vir Biotechnology, Inc. · CIK 1706431 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.